Manufacturer record

Pratima Pharmaceuticals G.No. 56/3: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Pratima Pharmaceuticals G.No. 56/3 (Maharashtra) were declared Not of Standard Quality between April 2025 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

1 record linked to Pratima Pharmaceuticals G.No. 56/3 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2025 to Apr 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2025
1
Products affected
Identification
Most common failure
Apr 2025
Latest alert

Flagged batches per year

2025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ronnin 500mg Tablets (Azithromycin Tablets IP 500mg) PPTC082Mfg 2023-11 · Exp 2026-10 The sample does not give IP identification test for the presence of Azithromycin. The sample is declared as spurious vide section 17-B(d) of the Drugs and Cosmetics Act, 1940 and Rules, 1945 thereunderIdentification State Lab MaharashtraState lab Apr 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.